Moshe Shoham Sells 33,700 Shares of Microbot Medical Inc (MBOT) Stock
Microbot Medical Inc (NASDAQ:MBOT) Director Moshe Shoham sold 33,700 shares of the firm’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $1.50, for a total value of $50,550.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Microbot Medical Inc (NASDAQ MBOT) traded down 6.34% during midday trading on Tuesday, hitting $1.33. The stock had a trading volume of 1,850,890 shares. The stock’s market cap is $58.57 million. Microbot Medical Inc has a one year low of $1.00 and a one year high of $15.66. The firm has a 50 day moving average price of $1.15 and a 200 day moving average price of $2.53.
Microbot Medical (NASDAQ:MBOT) last posted its quarterly earnings results on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.48) by $0.44. Equities analysts expect that Microbot Medical Inc will post ($25.02) EPS for the current year.
An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. boosted its position in shares of Microbot Medical Inc (NASDAQ:MBOT) by 252.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 159,992 shares of the biotechnology company’s stock after purchasing an additional 114,561 shares during the period. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 at the end of the most recent reporting period. 4.72% of the stock is owned by institutional investors and hedge funds.
Microbot Medical Company Profile
Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.
Receive News & Ratings for Microbot Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.